logo
  Home | Contact us | Browse | Quick Search by UniProtKB ID, Keyword, PDBID

Menu:

Latest news:

Sep. 10, 2014:
A total of 174 experimentally verified S-nitrosylation sites on 94 S-nitrosylated proteins from individualized human colorectal cancer tissues using a label-free quantitation strategy.

Read more...


Protein Name: Ras-related protein Rap-1b

UniprotKB/SwissProt ID: RAP1B_MOUSE (Q99JI6)

Gene Name: Rap1b

Organism: Mus musculus (Mouse).

Function: GTP-binding protein that possesses intrinsic GTPase activity. Contributes to the polarizing activity of KRIT1 and CDH5 in the establishment and maintenance of correct endothelial cell polarity and vascular lumen. Required for the localization of phosphorylated PRKCZ, PARD3 and TIAM1 to the cell junction. Plays a role in the establishment of basal endothelial barrier function (By similarity).

Other Modifications: View all modification sites in dbPTM

Protein Subcellular Localization: Cell membrane (By similarity). Cytoplasm, cytosol (By similarity). Cell junction (By similarity). Note=May shuttle between plasma membrane and cytosol. Presence of KRIT1 and CDH5 is required for its localization to the cell junction (By similarity).

Network with metabolic pathway:
Kegg map ID Pathway Link
map04720Long-term potentiation
map04670Leukocyte transendothelial migration
map04722Neurotrophin signaling pathway
map04972Pancreatic secretion
map05211Renal cell carcinoma
map04010MAPK signaling pathway
map04062Chemokine signaling pathway
map04510Focal adhesion
Graphical Visualization of S-nitrosylation Sites:
Overview of Protein S-nitrosylation Sites with Functional and Structural Information
InterPro ID Domain
IPR001806
IPR003577
IPR005225
IPR013753

The S-nitrosylation sites of RAP1B_MOUSE

No. Position S-nitrosylated Peptide Secondary Structure of S-nitrosylated Peptide Solvent Accessibility of nitrosylated Site Substrate Motifs PubMed ID Experiment
1118DVPMILVGNK C DLEDERVVGK CCEEEEEEEC C CCCCCCCCCH 9.29%MC0221278135in vitro
2141GQNLARQWNN C AFLESSAKSK HHHHHHHHCC C EEEEEEECCC 2.27%MC1324895380-
3141GQNLARQWNN C AFLESSAKSK HHHHHHHHCC C EEEEEEECCC 2.27%MC1320925432in vivo
4141GQNLARQWNN C AFLESSAKSK HHHHHHHHCC C EEEEEEECCC 2.27%MC1321278135in vitro